200 related articles for article (PubMed ID: 32013938)
1. Limited utility of qPCR-based detection of tumor-specific circulating mRNAs in whole blood from clear cell renal cell carcinoma patients.
Simonovic S; Hinze C; Schmidt-Ott KM; Busch J; Jung M; Jung K; Rabien A
BMC Urol; 2020 Feb; 20(1):7. PubMed ID: 32013938
[TBL] [Abstract][Full Text] [Related]
2. YRNA Expression Profiles are Altered in Clear Cell Renal Cell Carcinoma.
Nientiedt M; Schmidt D; Kristiansen G; Müller SC; Ellinger J
Eur Urol Focus; 2018 Mar; 4(2):260-266. PubMed ID: 28753785
[TBL] [Abstract][Full Text] [Related]
3. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma.
Schrödter S; Braun M; Syring I; Klümper N; Deng M; Schmidt D; Perner S; Müller SC; Ellinger J
Mol Cancer; 2016 Feb; 15():10. PubMed ID: 26831905
[TBL] [Abstract][Full Text] [Related]
4. Serum miR-122-5p and miR-206 expression: non-invasive prognostic biomarkers for renal cell carcinoma.
Heinemann FG; Tolkach Y; Deng M; Schmidt D; Perner S; Kristiansen G; Müller SC; Ellinger J
Clin Epigenetics; 2018; 10():11. PubMed ID: 29410711
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in Serum Exosomes as Potential Biomarkers in Clear-cell Renal Cell Carcinoma.
Zhang W; Ni M; Su Y; Wang H; Zhu S; Zhao A; Li G
Eur Urol Focus; 2018 Apr; 4(3):412-419. PubMed ID: 28753793
[TBL] [Abstract][Full Text] [Related]
6. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
Guan L; Tan J; Li H; Jin X
Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
[TBL] [Abstract][Full Text] [Related]
7. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
[TBL] [Abstract][Full Text] [Related]
8. Identification of dysregulated serum miR-508-3p and miR-885-5p as potential diagnostic biomarkers of clear cell renal carcinoma.
Liu S; Deng X; Zhang J
Mol Med Rep; 2019 Dec; 20(6):5075-5083. PubMed ID: 31661117
[TBL] [Abstract][Full Text] [Related]
9. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma.
Yang K; Lu XF; Luo PC; Zhang J
Biomed Res Int; 2018; 2018():9303486. PubMed ID: 30406146
[No Abstract] [Full Text] [Related]
10. PIWI-Interacting RNA Pathway Genes: Potential Biomarkers for Clear Cell Renal Cell Carcinoma.
Heng B; Xie X; Zeng W; Li H; Shi L; Ye W; Wu F
Dis Markers; 2022; 2022():3480377. PubMed ID: 35273654
[TBL] [Abstract][Full Text] [Related]
11. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of long non-coding RNA ENSG00000241684 is associated with poor prognosis in advanced clear cell renal cell carcinoma.
Su H; Wang H; Shi G; Zhang H; Sun F; Ye D
Eur J Surg Oncol; 2018 Jun; 44(6):840-846. PubMed ID: 29433989
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of Aquaporin 9 expression in clear cell renal cell carcinoma.
Xu WH; Shi SN; Xu Y; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
J Transl Med; 2019 Nov; 17(1):363. PubMed ID: 31703694
[TBL] [Abstract][Full Text] [Related]
14. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
15. Screening, identification and validation of CCND1 and PECAM1/CD31 for predicting prognosis in renal cell carcinoma patients.
Yang JF; Shi SN; Xu WH; Qiu YH; Zheng JZ; Yu K; Song XY; Li F; Wang Y; Wang R; Qu YY; Zhang HL; Zhou XQ
Aging (Albany NY); 2019 Dec; 11(24):12057-12079. PubMed ID: 31850854
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of OCLN and GAS1 in clear cell renal cell carcinoma.
Conceição AL; Da Silva CT; Badial RM; Valsechi MC; Stuqui B; Gonçalves JD; Jasiulionis MG; De Freitas Calmon M; Rahal P
Oncol Rep; 2017 Mar; 37(3):1487-1496. PubMed ID: 28184927
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of plasma and tissue S100A4 protein and mRNA levels as potential markers of metastasis and prognosis in clear cell renal cell carcinoma.
Yang H; Zhao K; Yu Q; Wang X; Song Y; Li R
J Int Med Res; 2012; 40(2):475-85. PubMed ID: 22613408
[TBL] [Abstract][Full Text] [Related]
18. Integrative analysis of dysregulated microRNAs and mRNAs in multiple recurrent synchronized renal tumors from patients with von Hippel-Lindau disease.
Gattolliat CH; Couvé S; Meurice G; Oréar C; Droin N; Chiquet M; Ferlicot S; Verkarre V; Vasiliu V; Molinié V; Méjean A; Dessen P; Giraud S; Bressac-De-Paillerets B; Gardie B; Tean Teh B; Richard S; Gad S
Int J Oncol; 2018 Oct; 53(4):1455-1468. PubMed ID: 30066860
[TBL] [Abstract][Full Text] [Related]
19. Fifteen hub genes associated with progression and prognosis of clear cell renal cell carcinoma identified by coexpression analysis.
Wang Y; Chen L; Wang G; Cheng S; Qian K; Liu X; Wu CL; Xiao Y; Wang X
J Cell Physiol; 2019 Jul; 234(7):10225-10237. PubMed ID: 30417363
[TBL] [Abstract][Full Text] [Related]
20. PLAGL1 (ZAC1/LOT1) Expression in Clear Cell Renal Cell Carcinoma: Correlations with Disease Progression and Unfavorable Prognosis.
Godlewski J; Krazinski BE; Kowalczyk AE; Kiewisz J; Kiezun J; Kwiatkowski P; Sliwinska-Jewsiewicka A; Maslowski Z; Kmiec Z
Anticancer Res; 2016 Feb; 36(2):617-24. PubMed ID: 26851016
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
